Top 10 heart disease journals

As the leading cause of morbidity among adults, heart disease is responsible for more than 17.9 million deaths globally per year.
Cardiovascular Disease (CVD) is the umbrella term for a range of diseases which affect the heart and its blood vessels, including coronary artery disease, heart rhythm issues (arrhythmias), congenital heart defects, heart valve disease, disease of the heart muscle and heart infection. Heart disease is also linked to strokes, aneurysms and an increased risk of dementia.
But with CVD a largely preventable disease (aside from congenital heart defects and a few other unavoidable risk factors – such as age, gender, ethnicity and family history), there is much that can be done to significantly reduce deaths worldwide from CVD.
So as a nod to February being National Heart Month (and Congenital Heart Defect week February 7 – 14), we’ve put together a list of the Top 10 heart disease/CVD journals to watch in 2022. By continuing to build knowledge of this critical health issue and keeping up to date with research, medical professionals will be able to continue providing best practice for their patients.
Journal Metrics
Impact factor: is based on Web of Science data and only includes documents such as articles and reviews. It measures the average number of times an article is cited by other journal articles and documents. An impact factor of 3 or more is considered good, 1 is average. This list uses the 2-year impact factor from SCImago.
CiteScore: is based on Scopus data for all indexed documents, including articles, letters and editorials. Like impact factor, it measures the average citations received per document published in a journal over a 4-year time period.
Impact factor and CiteScore have the most meaning when used to compare journals within the same therapeutic area of subject. Many academics value a journal’s impact factor over its Citescore; therefore they will use the impact factor to rank other journals in the same field.
SCImago Journal Rank (SJR): measures the citations received from a journal but it also considers the importance of the journal where the citations have come from. This measurement can be helpful to rank journals within the same field and category.
Source Normalized Impact per Paper (SNIP): measures citations weighted by subject field. A SNIP over 1.0 means a journal has more citations than average.
JAHA/Journal of the American Heart Foundation
Impact Factor: 4.605
CiteScore: 5.011
SJR: 2.494
SNIP: 2.49
The Journal of the American Heart Foundation is an Open Access journal, providing free content to read, download and share. As a global forum for basic and clinical research, JAHA examines all types of original research articles including human and laboratory animal-based experiments alongside high-quality clinical, epidemiological and health care policy papers.
Articles are published individually online and issues are compiled 24 times per year.
Congenital Heart Disease
Impact Factor: 2.007
CiteScore: 3.4
SJR: 0.828
SNIP: 1.0
While the number of infants born with congenital heart disease (CHD) each year is only around 1% of the population, CHD is a leading cause of birth defect-associated infant illness and death. Congenital Heart Disease is an open-access journal owned by Tech Science Press and includes clinical studies, invited editorials, reviews, case reports, articles on the history and development of CHD and continuing medical education material. It’s publication frequency is bi-monthly.
Journal of the American College of Cardiology
Impact Factor: 24.094
CiteScore: 33.1
SJR: 10.315
SNIP: 7.608
The journal of the American College of Cardiology was established in 1983, and since then has become a leader in its field, publishing original, peer-reviewed clinical and experimental reports on all aspects of CVD, including coronary artery and valve disease, CHD, vascular surgery, drug treatment, new diagnostic techniques and findings from the laboratory, as well as a studies of new therapies.
European Journal of Heart Failure
Impact Factor: 15.534
CiteScore: 22.0
SJR: 5.149
SNIP: 6.919
Dedicated to advancing the knowledge of those in the field of heart failure, the European Journal of Heart Failure is the international journal of the Heart Failure Association (part of the European Society of Cardiology). The journal has both Open Access and subscription-based articles.
Some of the most recent include the new European Society of Cardiology guidelines on heart failure, preventing heart failure and quality indicators for the care and outcomes of adults with heart failure.
The Journal of the American Medical Association - Cardiology
Impact Factor: 14.68
CiteScore: 22.6
SJR: 6.108
SNIP: 5.05
From original research to reviews, informative opinions which advance the science and practice of cardiology, enhance cardiovascular health and inform health care policy, the Journal of the American Medical Association Cardiology is a monthly peer-reviewed journal that was established in 2016. It focuses on all aspects of cardiovascular medicine as well as epidemiology, prevention, diagnostic testing and global health.
Nature Reviews Cardiology
Impact Factor: 32.42
CiteScore: 22.50
SJR: 5.495
SNIP: 6.548
Nature Reviews cardiology is a part of the Nature Reviews portfolio of journals, and their content is written by internationally renowned clinicians, academics and researchers. It is targeted towards readers in the biological and medical sciences – from a postgraduate level upwards. The journal publishes research highlights, comments, news, reviews, consensus statements and perspectives relevant to practising cardiologists and cardiovascular research scientists.
Recent articles include clinical observations and potential mechanisms of myocarditis after COVID-19 mRNA vaccination and bioengineering approaches to treat the failing heart – from cell biology to 3D printing.
European Heart Journal
Impact Factor: 29.983
CiteScore: 20.4
SJR: 4.336
SNIP: 6.362
As an official journal of the European Society of Cardiology, the European Heart Journal is an international, english-language, peer-reviewed journal that is published weekly. From articles related to research findings, technical evaluations and reviews, it also provides a forum for the exchange of information on all aspects of cardiovascular medicine.
American Heart Journal
Impact Factor: 4.749
CiteScore: 7.1
SJR: 2.925
SNIP: 3.683
The American Heart Journal is published by Elsevier, and aims to provide its readers primary investigation, scholarly review and opinion on the practice of cardiovascular medicine. They particularly encourage the submission of three types of reports that are not frequently published in cardiovascular journals – negative clinical studies, reports on study designs and studies that involve the organization of medical care.
Cardiovascular Research
Impact Factor: 10.787
CiteScore: 12.6
SJR: 2.774
SNIP: 5.32
From the European Society of Cardiology comes Cardiovascular Research, an international journal for basic and translational research that spans all topics within cardiology and cardiovascular biology. The journal aims to enhance insights into CVD and prospects for innovation in this field. Most recent articles include age-related enhanced degeneration of bioprosthetic valves and the sympathetic nervous system exacerbates carotid body sensitivity in hypertension.
American Journal of Cardiology
Impact Factor: 2.778
CiteScore: 4.6
SJR: 1.394
SNIP: 2.55
The American Journal of Cardiology is published 24 times a year, and is an independent global journal for CVD specialists and internists with a subspeciality in cardiology. Focusing on the practical, clinical approach to the diagnosis and treatment of CVD, also included are editorials, reader’s comments and symposia.
Their most cited articles over the past three years include the meta-analysis of effect of statins in patients with Covid-19 and hospital-level disparities in the outcomes of acute myocardial infarction with cardiogenic shock.
References
SCImago Journal & Country Rank
We'll deliver straight to your inbox
Discover the Power of Communication with Rx
Embark on your medcomms journey with Rx today and experience the difference of working with a world-class medical communications agency.
